[EN] GPR120 RECEPTOR AGONISTS AND USES THEREOF<br/>[FR] AGONISTES DU RÉCEPTEUR GPR120 ET LEURS UTILISATIONS
申请人:METABOLEX INC
公开号:WO2011159297A1
公开(公告)日:2011-12-22
GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
Some work leading to syntheses of oestrone is presented. It was generally found necessary to protect the 1-carbonyl function in 5,6,7,7a-tetrahydro-8β-methylindane-1,5-dione before the introduction of alkyl groups at position 4. Alkylations of 2-methylcyclopentane-1,3-dione have been made and the results compared with similar studies on 2-methylcyclohexane-1,3-dione.
Synthesis of novel molecular probes inspired by harringtonolide
作者:Vinayak Hegde、Marc Campitelli、Ronald J. Quinn、David Camp
DOI:10.1039/c1ob05299c
日期:——
A novel harringtonolide-inspired scaffold containing a cycloheptatriene ring and two fused cyclopentane rings has been synthesised from simple starting materials. The scaffold, containing a similar substitution pattern and relative stereochemistry to the complex diterpenoid, has been enumerated into a small library of derivatives. One of these library members has been converted into a sub-library of substituted triazoles using copper-catalysed azide-alkyne cycloaddition (click) chemistry. The scaffold may be useful in drug discovery or in the preparation of additional molecular probes for chemical biology.
GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.